Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
61M
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
45.3M
-
Shares change
-
+15M
-
Total reported value, excl. options
-
$947M
-
Value change
-
+$330M
-
Put/Call ratio
-
0.48
-
Number of buys
-
77
-
Number of sells
-
-36
-
Price
-
$20.89
Significant Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) as of Q3 2022
129 filings reported holding PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q3 2022.
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.3M shares
of 61M outstanding shares and own 74.38% of the company stock.
Largest 10 shareholders include FMR LLC (6.09M shares), Redmile Group, LLC (4.51M shares), TRV GP III, LLC (3.84M shares), CHI Advisors LLC (3.41M shares), TRV GP IV, LLC (2.13M shares), Avidity Partners Management LP (1.98M shares), JENNISON ASSOCIATES LLC (1.74M shares), VANGUARD GROUP INC (1.6M shares), FRANKLIN RESOURCES INC (1.49M shares), and Deep Track Capital, LP (1.4M shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.